Each year in the United States, seasonal influenza kills more than 36,000 people and hospitalizes 200,000 others. Globally, annual epidemics cause about 250,000 to 500,000 deaths. Scientists in NIAID labs and at universities and medical research institutions worldwide are working together to find better ways to prevent, diagnose, and treat seasonal and pandemic influenza, including H1N1 flu. For the latest in NIAID-supported influenza research, please see Recent Scientific Findings.
Vaccine and Treatment Evaluation Units (VTEUs) are launching clinical trials of H1N1 vaccines. (Also read the Q&A)
Read about what researchers have learned from the 1918 pandemic.
Report of the Blue Ribbon Panel on Influenza Research
2009 Progress Report to the Report of the Blue Ribbon Panel on Influenza Research, NIAID (PDF)
NIAID Influenza Antiviral Development Workshop: New Generation (PDF)
NIAID Media Availability: NIAID Scientists View Past Flu Pandemics for Clues to Future Course of 2009 H1N1 Virus—Aug. 11, 2009
NIAID Set to Launch Clinical Trials to Test 2009 H1N1 Influenza Vaccine Candidates—July 22, 2009
Q & A: Clinical Trials of 2009 H1N1 Influenza Vaccines Conducted by the NIAID-Supported Vaccine and Treatment Evaluation Units—July 22, 2009
All Flu News Releases
View how a mutation of genes enables the flu virus to escape the body's defenses.
View how a genetic change enables a flu strain to jump from one animal species to another.
Volunteer for NIAID-funded clinical studies related to flu on ClinicalTrials.gov.
View a list of links for for more information about influenza.
US Puts Flu Vaccines on Trial (Non-government)
NIAID Publications order form
Order Publications